Nanomix Corporation (NNMX)

OTCMKTS: NNMX · Delayed Price · USD
0.0001
0.00 (0.00%)
Jul 18, 2024, 4:00 PM EDT - Market closed
Market Cap 4.90K
Revenue (ttm) n/a
Net Income (ttm) -4.18M
Shares Out 49.00M
EPS (ttm) -0.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 315
Open 0.0001
Previous Close n/a
Day's Range n/a
52-Week Range 0.0001 - 0.0158
Beta 1.15
Analysts n/a
Price Target n/a
Earnings Date Apr 10, 2023

About NNMX

Nanomix Corporation develops and commercializes mobile point-of-care diagnostic system that is used in performing a range of in vitro diagnostic tests in various environments. Its products are designed to enhance healthcare delivery by bringing diagnostic information to the point of initial patient interaction, whether in the hospital or in settings, such as nursing facilities, elderly homes, urgent care centers, airports, schools, and others. The company is also developing a pipeline of other tests designed to enhance patient outcomes by makin... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2000
Employees 30
Stock Exchange OTCMKTS
Ticker Symbol NNMX
Full Company Profile

Financial Performance

In 2022, Nanomix's revenue was $15,450, a decrease of -89.10% compared to the previous year's $141,778. Losses were -$16.23 million, 38.9% more than in 2021.

Financial Statements

News

Nanomix Announces Equity Investment from Senior Executive of Woodley Equipment Company, Ltd. at a Premium to Market

SAN LEANDRO, Calif, April 13, 2023 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostic...

1 year ago - GlobeNewsWire

Nanomix Appoints Finance Veteran Chris Hetterly as Chief Financial Officer

SAN LEANDRO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in mobile, affordable, point-of-care (POC) diagnostics, today announced ...

1 year ago - GlobeNewsWire

Nanomix Enters into Distribution Agreement for the eLab System with Gepa Srl in Italy

SAN LEANDRO, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostic...

1 year ago - GlobeNewsWire

Nanomix Enters into an Exclusive Veterinary Distribution Agreement for the eLab System with Woodley Equipment Company, Ltd.

SAN LEANDRO, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostic...

1 year ago - GlobeNewsWire

Nanomix Enters into Multi-Country Distribution Agreement for the eLab System with Mast Group Limited

SAN LEANDRO, Calif., Nov. 04, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostic...

1 year ago - GlobeNewsWire

Nanomix Enters into Distribution Agreement for the eLab System with Diaclinic SpA in Chile

SAN LEANDRO, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care (POC) diagnostic...

1 year ago - GlobeNewsWire

Nanomix Enters into Distribution Agreement for the eLab System and Future New Products with IPS Genomix s.a.l. in the Middle East

SAN LEANDRO, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, to...

2 years ago - GlobeNewsWire

Nanomix Announces Agreement with Mobility Health to Co-Develop a Lab Development Test for Evaluating Levels of COVID-19 Circulating Antibodies

Point-of-care technology to offer patients a timely, highly accurate status of their protection against COVID-19 Point-of-care technology to offer patients a timely, highly accurate status of their pr...

2 years ago - GlobeNewsWire

Nanomix Appoints Industry Veteran Tadd S. Lazarus, M.D.

SAN LEANDRO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, tod...

2 years ago - GlobeNewsWire

Nanomix Enters into Distribution Agreement for the eLab System and Future New Products with BIOASIA PTE LTD in Singapore

SAN LEANDRO, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, tod...

2 years ago - GlobeNewsWire

Nanomix Announces ISO 13485:2016 Certification for its New Facility in San Leandro, CA

SAN LEANDRO, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in mobile, affordable, point-of-care diagnostics, today announced that i...

2 years ago - GlobeNewsWire

Nanomix Announces Appoints Life Sciences Executive Thomas Schlumpberger as Chief Executive Officer and Member of the Board of Directors

SAN LEANDRO, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in mobile, affordable, point-of-care diagnostics, today announced the ap...

2 years ago - GlobeNewsWire

Nanomix Announces Distribution Agreement for the eLab System with Biotron Ltd. in Israel

SAN LEANDRO, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, tod...

2 years ago - GlobeNewsWire

Nanomix Initiates New Clinical Study for the eLab S1 Panel

Study incorporates the use of the Nanomix eLab® S1 Panel within the Emergency Department of Hospital Clinico San Carlos in Madrid, Spain Study incorporates the use of the Nanomix eLab® S1 Panel within...

2 years ago - GlobeNewsWire

Nanomix Receives IVDR Certification for the eLab Analyzer

IVDR certification enables Nanomix to market its eLab analyzer in the European Union under the newly established regulatory guidelines IVDR certification enables Nanomix to market its eLab analyzer in...

2 years ago - GlobeNewsWire

Nanomix Granted CE Mark for eLab S1 Assay Panel for Whole Blood Samples

EMERYVILLE, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today...

2 years ago - GlobeNewsWire

Nanomix Announces Upgrade to OTCQB® Venture Market

EMERYVILLE, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCQB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, is pl...

2 years ago - GlobeNewsWire

Nanomix Receives CE Mark for its eLab COVID-19 Rapid Point-of-Care Antigen Panel

EMERYVILLE, Calif, May 20, 2022 (GLOBE NEWSWIRE) -- Nanomix Corporation (OTCBB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today ...

2 years ago - GlobeNewsWire